Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pathogenic Exosomes During Herpes Zoster Mediate Increased Vascular Dementia Risk.

NCT06903078 is registered in ClinicalTrials.gov with Center for Clinical Studies, Texas as lead sponsor.

NCT NCT06903078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06903078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pathogenic Exosomes During Herpes Zoster Mediate Increased Vascular Dementia Risk.
Lead sponsor
Center for Clinical Studies, Texas
Phase
Observational
Overall status
Recruiting
Start date
February 13, 2025
Completion date
August 31, 2030
Enrollment
375 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster (hz), vascular dementia